GALANTAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Galantamine patents expire, and when can generic versions of Galantamine launch?
Galantamine is a drug marketed by Aurobindo Pharma, Barr, Impax Labs, Pharmobedient, Sun Pharm, Watson Labs, Hikma, Apotex Inc, Aurobindo Pharma Ltd, Chartwell Rx, Heritage Pharma, Mylan, Sandoz, Senores Pharms, Yabao Pharm, and Zydus Pharms Usa Inc. and is included in nineteen NDAs.
The generic ingredient in GALANTAMINE is galantamine hydrobromide. There are fifteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the galantamine hydrobromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Galantamine
A generic version of GALANTAMINE was approved as galantamine hydrobromide by BARR on August 28th, 2008.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for GALANTAMINE?
- What are the global sales for GALANTAMINE?
- What is Average Wholesale Price for GALANTAMINE?
Summary for GALANTAMINE
| US Patents: | 0 |
| Applicants: | 16 |
| NDAs: | 19 |
| Drug Prices: | Drug price information for GALANTAMINE |
| DailyMed Link: | GALANTAMINE at DailyMed |


